Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (231-240 of 451) with videos related to

Pageof 46
Sort By:
BMJ Open|November 14, 2019
Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis updateAysegul Erman, Murray D Krahn, Tawnya Hansen, et al.
Plos One|July 19, 2012
Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009Nathaniel Jembere, Michael A Campitelli, Morris Sherman, et al.
Viruses|February 27, 2026
Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/VelpatasvirGia Landry, Mark Sulkowski, Jordan J Feld, et al.
Journal of Viral Hepatitis|December 15, 2017
Estimating chronic hepatitis C prognosis using transient elastography-based liver stiffness: A systematic review and meta-analysisA Erman, A Sathya, A Nam, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2023
Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virusAlexander I Mosa, David S Campo, Yury Khudyakov, et al.
Nature Communications|November 17, 2022
Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunityDeanna M Santer, Daniel Li, Yanal Ghosheh, et al.
Journal of Viral Hepatitis|February 22, 2024
Real-world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, CanadaB Wolfson-Stofko, G Hirode, A Vanderhoff, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 5, 2019
Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus-Related Acute Liver FailureVeeral Ajmera, Hailiang Huang, Doan Dao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2021
Progress towards hepatitis C virus elimination in high-income countries: An updated analysisIvane Gamkrelidze, Jean-Michel Pawlotsky, Jeffrey V Lazarus, et al.
Journal of Viral Hepatitis|September 8, 2020
Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patientsKin Seng Liem, David K Wong, Scott Fung, et al.
Pageof 46

Showing results (231-240 of 451) with videos related to

Sort By:
Pageof 46
BMJ Open|November 14, 2019
Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis updateAysegul Erman, Murray D Krahn, Tawnya Hansen, et al.
Plos One|July 19, 2012
Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009Nathaniel Jembere, Michael A Campitelli, Morris Sherman, et al.
Viruses|February 27, 2026
Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/VelpatasvirGia Landry, Mark Sulkowski, Jordan J Feld, et al.
Journal of Viral Hepatitis|December 15, 2017
Estimating chronic hepatitis C prognosis using transient elastography-based liver stiffness: A systematic review and meta-analysisA Erman, A Sathya, A Nam, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2023
Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virusAlexander I Mosa, David S Campo, Yury Khudyakov, et al.
Nature Communications|November 17, 2022
Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunityDeanna M Santer, Daniel Li, Yanal Ghosheh, et al.
Journal of Viral Hepatitis|February 22, 2024
Real-world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, CanadaB Wolfson-Stofko, G Hirode, A Vanderhoff, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 5, 2019
Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus-Related Acute Liver FailureVeeral Ajmera, Hailiang Huang, Doan Dao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2021
Progress towards hepatitis C virus elimination in high-income countries: An updated analysisIvane Gamkrelidze, Jean-Michel Pawlotsky, Jeffrey V Lazarus, et al.
Journal of Viral Hepatitis|September 8, 2020
Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patientsKin Seng Liem, David K Wong, Scott Fung, et al.
Pageof 46